文献速递母胎医学产科

双胎选择性胎儿生长受限管理研究的核心结局集

Core outcome set for studies investigating management of selective fetal growth restriction in twins.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-03-29

本研究通过系统综述、三轮德尔菲调查和国际共识会议制定双胎选择性胎儿生长受限(sFGR)管理研究的核心结局集。系统综述纳入39项研究识别96个结局,103名来自23个国家的参与者完成首轮德尔菲调查,最终共识会议同意11个核心结局,包括活产、出生孕周、出生体重等。作者认为未来试验采用这些结局有助于提高研究的临床相关性,但核心结局的定义和测量方法仍需达成共识。

要点

  • 核心结局集涵盖11项结局,包括活产、出生孕周、出生体重、双胎出生体重不一致等。
  • 共识定义为德尔菲调查第三轮利克特评分≥8分。
  • 作者认为未来试验采用这些结局有助于提高研究的临床相关性。

核心结论

  • 该核心结局集代表了一个大型且多元化的国际合作者群体的共识。
  • 作者认为在未来试验中使用这些结局应有助于提高该疾病研究的临床相关性。
  • 现在需要就核心结局的定义和测量方法达成共识。

研究设计与样本

  • 建立国际指导组,由临床医生、研究人员和有sFGR经验的患者组成,监督核心结局集的制定过程。
  • 通过系统综述识别文献中报告的结局,并据此设计三轮德尔菲调查。
  • 临床医生、研究人员以及患者和家庭代表参与调查,结局按利克特量表从1分(对决策重要性有限)到9分(对决策至关重要)评分。
  • 共识预先定义为德尔菲调查第三轮利克特评分≥8分。
  • 参与者随后受邀参加国际利益相关者会议,采用改良名义组技术审议共识结局并商定最终核心结局集。

主要发现

  • 系统综述从39项研究中识别出96个结局。
  • 来自23个国家的103名参与者完成了第一轮德尔菲调查,其中88人完成了全部三轮。
  • 29个结局达到预先设定的共识标准,并与6个额外结局一起在共识制定会议上使用改良名义组技术进行了优先排序。
  • 25名利益相关者参加了该会议,包括研究人员(n=3)、胎儿医学专家(n=3)、产科医生(n=2)、新生儿科医生(n=3)、助产士(n=4)、父母和家庭成员(n=6)、患者团体代表(n=3)和一名超声技师。
  • 共商定11个核心结局:活产、出生孕周、出生体重、双胎出生体重不一致、双胎之一死亡后存活双胎的死亡、妊娠期丢失或最终出院前丢失、父母压力、操作相关不良母体结局、新生儿住院时间、出生后影像学检查发现的神经系统异常和儿童期残疾。

关键数值与推荐

  • 共识标准为德尔菲调查第三轮利克特评分≥8分。
  • 利克特量表评分为1分(对决策重要性有限)至9分(对决策至关重要)。
  • 最终核心结局集包含11个核心结局:活产、出生孕周、出生体重、双胎出生体重不一致、双胎之一死亡后存活双胎的死亡、妊娠期丢失或最终出院前丢失、父母压力、操作相关不良母体结局、新生儿住院时间、出生后影像学检查发现的神经系统异常和儿童期残疾。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Selective fetal growth restriction (sFGR) occurs in monochorionic twin pregnancies when unequal placental sharing leads to restriction in the growth of just one twin. Management options include laser separation of the fetal circulations, selective reduction or expectant management, but what constitutes the best treatment is not yet known. New trials in this area are urgently needed but, in this rare and complex group, maximizing the relevance and utility of clinical research design and outputs is paramount. A core outcome set ensures standardized outcome collection and reporting in future research. The objective of this study was to develop a core outcome set for studies evaluating treatments for sFGR in monochorionic twins. METHODS: An international steering group of clinicians, researchers and patients with experience of sFGR was established to oversee the process of development of a core outcome set for studies investigating the management of sFGR. Outcomes reported in the literature were identified through a systematic review and informed the design of a three-round Delphi survey. Clinicians, researchers, and patients and family representatives participated in the survey. Outcomes were scored on a Likert scale from 1 (limited importance for making a decision) to 9 (critical for making a decision). Consensus was defined a priori as a Likert score of ≥ 8 in the third round of the Delphi survey. Participants were then invited to take part in an international meeting of stakeholders in which the modified nominal group technique was used to consider the consensus outcomes and agree on a final core outcome set. RESULTS: Ninety-six outcomes were identified from 39 studies in the systematic review. One hundred and three participants from 23 countries completed the first round of the Delphi survey, of whom 88 completed all three rounds. Twenty-nine outcomes met the a priori criteria for consensus and, along with six additional outcomes, were prioritized in a consensus development meeting, using the modified nominal group technique. Twenty-five stakeholders participated in this meeting, including researchers (n = 3), fetal medicine specialists (n = 3), obstetricians (n = 2), neonatologists (n = 3), midwives (n = 4), parents and family members (n = 6), patient group representatives (n = 3), and a sonographer. Eleven core outcomes were agreed upon. These were live birth, gestational age at birth, birth weight, intertwin birth-weight discordance, death of surviving twin after death of cotwin, loss during pregnancy or before final hospital discharge, parental stress, procedure-related adverse maternal outcome, length of neonatal stay in hospital, neurological abnormality on postnatal imaging and childhood disability. CONCLUSIONS: This core outcome set for studies investigating the management of sFGR represents the consensus of a large and diverse group of international collaborators. Use of these outcomes in future trials should help to increase the clinical relevance of research on this condition. Consensus agreement on core outcome definitions and measures is now required. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Townsend R, Duffy JMN, Sileo F, et al. Core outcome set for studies investigating management of selective fetal growth restriction in twins. Ultrasound Obstet Gynecol. 2020. PMID: 31273879. doi:10.1002/uog.20388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。